Patient info Open main menu

Fexofenadine Cipla 180 mg film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
180 mg
Contains active substance:

Patient leaflet - Fexofenadine Cipla 180 mg film-coated tablets

1. What Fexofenadine Cipla is and what it is used for

Fexofenadine Cipla contains fexofenadine hydrochloride, which is an antihistamine.

Fexofenadine Cipla 180 mg is used in adults and adolescents of 12 years and older to relieve the symptoms that occur with long term allergic skin reactions (chronic idiopathic urticaria) such as itching, swelling and rashes.

2. What you need to know before you take Fexofenadine Cipla

Do not take Fexofenadine Cipla:

  • if you are allergic to fexofenadine or any of the other ingredients of this medicine (listed in section 6). Warnings and precautions

Talk to your doctor, pharmacist or nurse before taking Fexofenadine Cipla if

  • you have problems with the way your liver or kidneys work;
  • you have or ever had heart disease, since this kind of medicine may lead to a fast or irregular heart beat;
  • you are elderly.

Children and adolescents

Fexofenadine Cipla 180 mg film-coated tablet is not recommended in children and adolescents below 12 years of age. Other medicines and Fexofenadine Cipla

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. If you are taking apalutamide (a medicine to treat prostate cancer), as the effect of fexofenadine may be decreased. Indigestion remedies containing aluminium and magnesium may affect the action of Fexofenadine Cipla, by lowering the amount of medicinal product absorbed.

It is recommended that you leave about 2 hours between the time that you take Fexofenadine Cipla and your indigestion remedy. Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Do not take Fexofenadine Cipla if you are pregnant, unless necessary.

Fexofenadine Cipla is not recommended during breast-feeding.

Driving and using machines

Fexofenadine Cipla is unlikely to affect your ability to drive or operatemachinery. However, you should check that these tablets donot make you feel sleepy or dizzy before driving or operatingmachinery.

Fexofenadine Cipla contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Fexofenadine Cipla

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. For adults and adolescents aged 12 years and over

The recommended dose is one tablet (180 mg) daily.

Take your tablet with water before a meal.

This medicine starts to relieve your symptoms within 1 hour and lasts for 24 hours.

Use in children and adolescents

Fexofenadine Cipla 180 mg film-coated tablet is not recommended in children and adolescents below 12 years of age. If you take more Fexofenadine Cipla than you should

If you take too many tablets, contact your doctor or the nearest hospital emergency department immediately. Symptoms of an overdose in adults are dizziness, drowsiness, fatigue and dry mouth.

If you forget to take Fexofenadine Cipla

Do not take a double dose to make up for a forgotten tablet.

Take the next dose at the usual time as prescribed by your doctor.

If you stop taking Fexofenadine Cipla

Tell your doctor if you want to stop taking Fexofenadine Cipla before you have finished your course of treatment. If you stop taking Fexofenadine Cipla earlier than planned, yoursymptoms may return.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor immediately and stop taking Fexofenadine Cipla if you experience:

  • Swelling of the face, lips, tongue or throat and difficulty breathing, as these may be signs of a serious allergic reaction. The following side effects have also been reported:

Common side effects (may affect up to 1 in 10 people):

  • Headache
  • Drowsiness
  • Feeling sick (nausea)
  • Dizziness

    Reference : 21098109

    CR : DSD-D-23-00167

    Ph_code : 2114_MINI

    Country : UK

    Type : (Safety)

    Date: 31/10/2023

    SAP Code: 21101474 (Ver. 01)

    Leaflet size: 190 x 380 mm

    Size after folding : 190 x 24 mm

    Path: D:

\

UK

Times New Roman Bold

Body text : 9pt

Sub Heading : 10pt

Main Heading : 12pt

Leading between two lines : 1pt Uncommon side effects (may affect up to 1 in 100 people):

  • Tiredness
  • Sleepiness.

Not known (frequency cannot be estimated from the available data):

  • Difficulty sleeping (insomnia)
  • Sleeping disorders
  • Bad dreams
  • Nervousness
  • Fast or irregular heart beat
  • Diarrhoea
  • Skin rash and itching
  • Hives
  • Serious allergic reactions which can cause swelling of the face, lips, tongue or throat, flushing, chest tightness, and difficulty breathing.
  • Blurred vision

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Fexofenadine Cipla

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is statedon the carton/label/blister after EXP. The expiry date refers to the last dayof that month.

This medicine does not require any special storage condition.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Fexofenadine Cipla contains:

  • The active substance is fexofenadine hydrochloride. Each tablet contains 180 mg of fexofenadine hydrochloride.
  • The other ingredients are:

    • Tablet core: microcrystalline cellulose, maize starch, croscarmellose sodium, povidone, magnesium stearate
    • Film coating: hypromellose, titanium dioxide (E171), macrogol, iron oxide yellow (E172) What Fexofenadine Cipla looks like and contents of the pack

Fexofenadine Cipla 180 mg film-coated tablets are yellow coloured, oblong, film-coated tablets plain on one side with a central score line on the other side. Dimensions: 17.00 x 8.00 mm

PVC/PVDC/Al blisters, packaged into cardboard boxes. 10, 15, 20, 30, 50, 100 and 200 (as 10x20) tablets per package. Not all packs sizes may be marketed

Marketing Authorisation Holder and Manufacturer:

Cipla (EU) Limited

Dixcart House, Addlestone Road,

Bourne Business Park,

Addlestone, Surrey,

KT15 2LE, United Kingdom

This leaflet was last revised in 11/2023.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 36390/0294

Last revision stated in the text: November 2023 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Fexofenadine Cipla 180 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Fexofenadine
Strength 180 mg
Pharmaceutical form Oral tablet
Yellow coloured, oblong, biconvex, film-coated tablet plain on one side with a central score line on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. Dimensions: 17.00 x 8.00 mm
How is it taken Oral
Excipients Microcrystalline cellulose,, Maize starch,, Croscarmellose sodium,, Povidone,, Magnesium stearate., Hypromellose,, Titanium dioxide (E171),, Macrogol,, Iron oxide yellow (E172),
Pack sizes 30 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 2 years
Storage This medicinal product does not require any special storage conditions
Drug group (ATC) Antihistamines for systemic use
  1. R Respiratory system drugs
    1. R06 Antihistamines for systemic use
      1. R06A Antihistamines for systemic use
        1. R06AX Other antihistamines for systemic use
          1. R06AX26 fexofenadine
Marketing authorisation PLGB 36390/0294 (first authorised 9 November 2021)
Marketing authorisation holder Cipla (EU) Limited
Codes GTIN 8901117086685 · BNF 03040100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.